USPTO serial 99348403
RIPPLE
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUBIN, DAVID I
- Law office
- TMEG LAW OFFICE 107
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RIPPLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dustin Luettgen
201 Haskins Way5th FloorSouth San Francisco, CA 94080Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Gene therapy preparations, namely, biological preparations for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology; gene delivery platform in the nature of biological delivery agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology. | ACTIVE | — |
| 009 | Downloadable computer operating software for operating ultrasound systems and ultrasound probes that are used for administering pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders. | ACTIVE | — |
| 010 | Ultrasound systems being medical ultrasound apparatus and ultrasound probes for medical use for administering pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders. | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for operating ultrasound systems and ultrasound probes that administer pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders; research and development in the field of gene therapy. | ACTIVE | — |
| 044 | Medical services for ultrasound mediated administration of pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 5, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 5, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 5, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 6, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 23, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 23, 2026 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 23, 2026 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jan 7, 2026 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 7, 2026 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 7, 2026 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 20, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2025 | NWAP | NEW APPLICATION ENTERED | — |